دورية أكاديمية

Thrombocytopenia associated with TAVI-The summary of possible causes.

التفاصيل البيبلوغرافية
العنوان: Thrombocytopenia associated with TAVI-The summary of possible causes.
المؤلفون: Mitrosz M; Department of Cardiac Surgery, Poland., Chlabicz M; Department of Cardiology, Poland., Hapaniuk K; Department of Cardiology, Poland., Kaminski KA; Department of Cardiology, Poland; Department of Population Medicine and Prevention of Civilization Diseases, Poland., Sobkowicz B; Department of Cardiology, Poland., Piszcz J; Department of Hematology, Poland., Dobrzycki S; Department of Invasive Cardiology, Medical University of Bialystok, Poland., Musial WJ; Department of Cardiology, Poland., Hirnle T; Department of Cardiac Surgery, Poland., Tycinska AM; Department of Cardiology, Poland. Electronic address: agnieszka.tycinska@gmail.com.
المصدر: Advances in medical sciences [Adv Med Sci] 2017 Sep; Vol. 62 (2), pp. 378-382. Date of Electronic Publication: 2017 May 25.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101276222 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1898-4002 (Electronic) Linking ISSN: 18961126 NLM ISO Abbreviation: Adv Med Sci Subsets: MEDLINE
أسماء مطبوعة: Publication: March, 2014- : Amsterdam : Elsevier
Original Publication: Białystok, Poland : Medical University of Białystok, [2006]-
مواضيع طبية MeSH: Thrombocytopenia/*etiology , Transcatheter Aortic Valve Replacement/*adverse effects, Humans ; Risk Factors
مستخلص: Thrombocytopenia (TP) following transcatheter aortic valve implantation (TAVI) procedure is a common phenomenon but the underlying mechanisms are neither well known nor described. Postinterventional severe TP is related to worse early and late outcome. Moreover, the statement of enhanced platelet and coagulation activation might justify even stronger antiplatelet and anticoagulation therapy following TAVI procedure. Thus, the examination of the pathomechanisms responsible for TP post TAVI seems to be crucial. Several hypotheses have been raised. TP can be caused by insufficient production or impaired platelet renewal. On the other hand, increased platelet activation, consumption and destruction might also be responsible for TP. These findings, mostly related to the procedure alone, need further investigation. Here, we summarize the potential multifactorial causes of post TAVI thrombocytopenia.
(Copyright © 2017 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: Causes of thrombocytopenia; Platelet function; TAVIAVR–aortic valve replacement
تواريخ الأحداث: Date Created: 20170528 Date Completed: 20180223 Latest Revision: 20180223
رمز التحديث: 20240628
DOI: 10.1016/j.advms.2017.04.003
PMID: 28550795
قاعدة البيانات: MEDLINE
الوصف
تدمد:1898-4002
DOI:10.1016/j.advms.2017.04.003